Lemaitre Vascular Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Public

  • Employees
  • 655

Employees

  • Stock Symbol
  • LMAT

Stock Symbol

  • Investments
  • 21

  • Share Price
  • $73.61
  • (As of Friday Closing)

Lemaitre Vascular General Information

Description

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Contact Information

Formerly Known As
Vascutech
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 63 Second Avenue
  • Burlington, MA 01803
  • United States
+1 (781)
Primary Industry
Other Devices and Supplies
Other Industries
Surgical Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 63 Second Avenue
  • Burlington, MA 01803
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lemaitre Vascular Stock Performance

As of 20-Nov-2026, Lemaitre Vascular’s stock price is $73.61. Its current market cap is $1.68B with 22.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$73.61 $74.80 $73.44 - $118.01 $1.68B 22.9M 278K $2.78

Lemaitre Vascular Financials Summary

As of 30-Sep-2026, Lemaitre Vascular has a trailing 12-month revenue of $269M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,702,786 1,682,411 1,966,115 1,183,524
Revenue 269,356 249,602 219,863 193,484
EBITDA 97,814 90,786 66,688 48,990
Net Income 63,335 57,734 44,038 30,105
Total Assets 656,032 615,690 551,817 346,778
Total Debt 188,851 185,592 185,685 19,095
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lemaitre Vascular Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lemaitre Vascular‘s full profile, request access.

Request a free trial

Lemaitre Vascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the tre
Other Devices and Supplies
Burlington, MA
655 As of 2025

Latham, NY
 

Alameda, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lemaitre Vascular Competitors (20)

One of Lemaitre Vascular’s 20 competitors is Angiodynamics, a Corporation company based in Latham, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Angiodynamics Corporation Latham, NY
Penumbra Formerly VC-backed Alameda, CA
Medtronic Corporation Minneapolis, MN
Teleflex Corporation Wayne, PA
Inari Medical Formerly VC-backed Irvine, CA
You’re viewing 5 of 20 competitors. Get the full list »

Lemaitre Vascular Patents

Lemaitre Vascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2012205353-A1 Systems and methods for remote endarterectomy Inactive 14-Jan-2011
CA-2824061-A1 Systems and methods for remote endarterectomy Inactive 14-Jan-2011
EP-2663247-A1 Systems and methods for remote endarterectomy Inactive 14-Jan-2011
WO-2012097292-A1 Systems and methods for remote endarterectomy Inactive 14-Jan-2011
JP-2013533772-A Over-the-wire barbarotome Inactive 22-Jun-2010 A61B17/320725
To view Lemaitre Vascular’s complete patent history, request access »

Lemaitre Vascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lemaitre Vascular Investments & Acquisitions (21)

Lemaitre Vascular’s most recent deal was a Corporate Asset Purchase with B. Braun (Vascular Assets) for . The deal was made on 01-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
B. Braun (Vascular Assets) 01-Oct-2026 Corporate Asset Purchase Buildings and Property
Prompt Serve 14-Mar-2023 Merger/Acquisition Distributors (Healthcare)
Lombard Medical (Aorfix an Endovascular Stent Graft in Burlington, Vermont) 01-Jan-2023 Corporate Asset Purchase Buildings and Property
Artegraft 22-Jun-2020 Merger/Acquisition Therapeutic Devices
Admedus (Biologic Patch Business) 11-Oct-2019 Merger/Acquisition Surgical Devices
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Lemaitre Vascular ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

31.94 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Lemaitre Vascular’s complete esg history, request access »

Lemaitre Vascular Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Artegraft North Brunswick, NJ 1993

Lemaitre Vascular FAQs

  • When was Lemaitre Vascular founded?

    Lemaitre Vascular was founded in 1983.

  • Where is Lemaitre Vascular headquartered?

    Lemaitre Vascular is headquartered in Burlington, MA.

  • What is the size of Lemaitre Vascular?

    Lemaitre Vascular has 655 total employees.

  • What industry is Lemaitre Vascular in?

    Lemaitre Vascular’s primary industry is Other Devices and Supplies.

  • Is Lemaitre Vascular a private or public company?

    Lemaitre Vascular is a Public company.

  • What is Lemaitre Vascular’s stock symbol?

    The ticker symbol for Lemaitre Vascular is LMAT.

  • What is the current stock price of Lemaitre Vascular?

    As of 20-Nov-2026 the stock price of Lemaitre Vascular is $73.61.

  • What is the current market cap of Lemaitre Vascular?

    The current market capitalization of Lemaitre Vascular is $1.68B.

  • What is Lemaitre Vascular’s current revenue?

    The trailing twelve month revenue for Lemaitre Vascular is $269M.

  • Who are Lemaitre Vascular’s competitors?

    Angiodynamics, Penumbra, Medtronic, Teleflex, and Inari Medical are some of the 20 competitors of Lemaitre Vascular.

  • What is Lemaitre Vascular’s annual earnings per share (EPS)?

    Lemaitre Vascular’s EPS for 12 months was $2.78.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process